Chaîne à température contrôlée - ressources techniques

Maricel CASTRO

La chaîne à température contrôlée (CTC) est une approche spécifique à court terme de gestion des vaccins qui permet de conserver les vaccins à des températures supérieures aux conditions de stockage à long terme de +2° à +8° C, pendant une période limitée, dans des conditions surveillées et contrôlées adaptées à la stabilité de l'antigène. Les conditions actuelles du programme de l'OMS pour la CTC comprennent une exposition unique juste avant l'administration, tolérant des températures ambiantes d'au moins 40°C pendant une durée limitée d'au moins trois jours, ces conditions de température et de temps étant incluses dans l'étiquette approuvée.

Cette page fournit une liste de ressources liées à la CTC, ainsi que des documents élaborés par le groupe de travail sur la CTC. L'objectif est de sensibiliser les parties prenantes multisectorielles et l'industrie à la CTC, d'impliquer davantage de partenaires par la promotion d'une vision et d'une stratégie communes autour de la CTC, d'encourager un dialogue constructif avec les fabricants sur la nécessité d'innover davantage en matière de vaccins et sur leur volonté d'envisager l'étiquetage CTC pour les vaccins nouveaux ou existants, d'accroître l'adoption par les pays de la mise en œuvre de la CTC pendant les campagnes de vaccination afin d'augmenter la couverture vaccinale et de générer davantage de données sur la CTC. Les ressources sont classées par catégorie :

 

Publications

TitreAuteurAnnéeTypeLangue
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns : adaptation guide and facilitators guideWorld Health Organization (WHO)2013GuidanceAnglais, Français
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns : training module for organizing immunization sessionsWorld Health Organization (WHO)2013TrainingAnglais, Français
Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns: guidance for immunization programme decision-makers and managersWorld Health Organization (WHO)2013GuidanceAnglais, Français
Delivering MenAfriVac using the controlled temperature chain approachPATH, World Health Organization (WHO)2013Case studyAnglais, Français
Controlled temperature chain for vaccination in low- and middle-income countries: a realist evidence synthesisChristopher P. Seaman, Anna-Lea Kahn, Debra Kristensen, Robert Steinglass, Dijana Spasenoska, Nick Scott, Christopher Morgan2022Journal articleAnglais
How to monitor temperatures in the vaccine supply chainUNICEF, World Health Organization (WHO)2015GuidanceAnglais, Français
Guidelines on the stability evaluation of vaccines for use under extended controlled temperature conditions, Annex 5, TRS No 999World Health Organization (WHO)2016GuidanceAnglais
Labelling Guidance for Controlled Temperature Chain (CTC) Qualification for Vaccine Manufacturers (2020) World Health Organization (WHO)2020GuidanceAnglais
Hepatitis B vaccines: WHO position paper - July 2017World Health Organization (WHO)2017GuidanceArabe, Chinois, Anglais, Français, Russe, Espagnol

 

Articles de revue

TitreAuteurAnnéeTypeLangue
Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countriesDebra D. Kristensen, Tina Lorenson, Kate Bartholomew, Shirley Villadiego2016Journal articleAnglais
An economic evaluation of the controlled temperature chain approach for vaccine logistics: evidence from a study conducted during a meningitis A vaccine campaign in TogoMercy Mvundura, Patrick Lydon, Abdoulaye Gueye, Ibnou Khadim Diaw, Dadja Essoya Landoh, Bafei Toi, Anna-Lea Kahn, Debra Kristensen2017Journal articleAnglais
Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of Meningitis A vaccine in ChadPatrick Lydon et al.2014Journal articleAnglais
A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chainRebecca F. Grais, Primitive Gakima, Paul Baoundoh, Mbaihol Tamadji, Martha H. Roper, Florence Fermon, Céline Langendorf, Camille Domicent, Aitana Juan-Giner, Simona Zipursky2014Journal articleAnglais
Countries’ interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regionsDörte Petit, Carole Tevi-Benissan, Joseph Woodring, Karen Hennessey, Anna-Lea Kahn2017Journal articleAnglais
Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccinesRaja Rao, Debra Kristensen, Anna-Lea Kahn2017Journal articleAnglais
Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in BeninSimona Zipursky, Mamoudou Harouna Djingarey, Jean-Claude Lodjo, Laifoya Olodo, Sylvestre Tiendrebeogo, Olivier Ronveaux2014Journal articleAnglais
Antivenoms, hepatitis B vaccine and oral polio vaccine can be considered for storage and handling outside the cold chain following the innovative 'controlled temperature chain' approachShereen H. Mohamed, Osama A. Hady, Mona T. Kashef, Hamdallah Zedan2022Journal articleAnglais
Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: a modelling and cost-optimisation studyChristopher P. Seaman, Christopher Morgan, Jess Howell, Yinzong Xiao, Wendy Spearman, Mark Sonderup2020Journal articleAnglais
A field based evaluation of adverse events following MenAfriVac® vaccine delivered in a controlled temperature chain (CTC) approach in Benin Christoph Steffen, Evariste Tokplonou, Philippe Jaillard, Roger Dia, Marie N Deye Bassabi Alladji, Bradford Gessner2014Journal articleAnglais
Impact of Controlled Temperature Chain (CTC) approach on immunization coverage achieved during the preventive vaccination campaign against meningitis A using MenAfriVac in Togo in 2014Dadja Essoya Landoh, Anna-Lea Kahn, Anani Lacle, Kodjovi Adjeoda, Bayaki Saka, Issifou Yaya, Danladi Ibrahim Nassoury, Assima Kalao, Makawa-Sy Makawa, Nsiari-Mueyi Joseph Biey, Andre Bita, Yaovi Temfa Toke, Petit Dörte, Lucile Imboua, Olivier Ronveaux2017Journal articleAnglais
Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling studyNick Scott, Anna Palmer, Christopher Morgan, Olufunmilayo Lesi, Wendy Spearman, Mark Sonderup, Margaret Hellard2018Journal articleAnglais
Evidence of Extended Thermo-Stability of Typhoid Polysaccharide Conjugate VaccinesFang Gao, Alastair Logan, Sarah Davis, Barbara Bolgiano, Sjoerd Rijpkema, Gopal Singh, Sai D. Prasad, Samuel Pradeep Dondapati, Gurbaksh Singh Sounkhla2021Journal articleAnglais
Using human papillomavirus (HPV) vaccine in controlled temperature chain (CTC): A solution looking for a problem? Or a solution to problems that are not systematically documented?Dijana Spasenoska, Paul Bloem, Hiroki Akaba, Anna-Lea Kahn2024Journal articleAnglais

 

Plaidoyer

TitreAuteurAnnéeTypeLangue
What is a controlled temperature chain? (CTC) - InfographicWorld Health Organization (WHO)2015Poster/infographicAnglais, Français
CTC FAQsControlled Temperature Chain Team2023PresentationAnglais, Français
CTC - Delivering vaccines more easilyWorld Health Organization (WHO)2015GuidanceAnglais, Français
Controlled temperature chain: Strategic Roadmap for Priority Vaccines 2017-2020World Health Organization (WHO)2018GuidanceAnglais
South Sudan conducts first phase of meningitis A campaign using a CTCWorld Health Organization (WHO)2015ReportAnglais
Immunization Practices Advisory Committee (IPAC) statement: out of cold chain (OCC) and controlled temperature chain (CTC) use of vaccinesIPAC Delivery Technologies Working Group2016GuidanceAnglais
Risk/Benefit considerations when deciding on CTCWorld Health Organization (WHO)2024Poster/infographicAnglais